Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Signatures Gets CE Mark for 'Superbugs' Kit

NEW YORK (GenomeWeb) – Australian diagnostics manufacturer Genetic Signatures announced today that it has received CE marking for a PCR-based kit to detect extended spectrum beta-lactamase (ESBL) and carbapenemase-producing organisms (CPOs).

The firm's EasyScreen ESBL & CPO Kit detects strains of antibiotic-resistant pathogens, often referred to as "superbugs," in less than three hours with minimal hands-on time. It detects a total of 16 beta-lactam and carbapenem-resistant pathogen targets.

The assay relies on the firm's 3base technology, a method using bisulfite conversion to reduce complexity in nucleic acid samples in order to improve specificity and sensitivity.

The firm said it will make the kit available in Europe through a hybrid of direct and distributor-led sales, and is now recruiting a direct sales team in Europe.

This the second Genetic Signatures product group to get CE marking following European approval last year for a suite of enteric pathogen detection assays, including ones for enteric viruses, bacteria, protozoa, and Clostridium difficile.

"This registration follows significant work from the Genetic Signatures team and ultimately reflects the significant potential of our 3base technology to make a real difference in pathogen detection and treatment processes," Genetic Signatures CEO John Melki said in a statement, adding that the approval should further increase the relevance of the company's product suite and sales potential with European customers.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.